Turning Point Therapeutics, Inc. Operating Income 2019-2022 | TPTX
Turning Point Therapeutics, Inc. operating income from 2019 to 2022. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Turning Point Therapeutics, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2021 | $-238 |
| 2020 | $-162 |
| 2019 | $-78 |
| 2018 | $-26 |
| 2017 | $-17 |
| Turning Point Therapeutics, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2022-06-30 | $-124 |
| 2022-03-31 | $-75 |
| 2021-12-31 | $-79 |
| 2021-09-30 | $-67 |
| 2021-06-30 | $-57 |
| 2021-03-31 | $-36 |
| 2020-12-31 | $-48 |
| 2020-09-30 | $-19 |
| 2020-06-30 | $-33 |
| 2020-03-31 | $-63 |
| 2019-12-31 | $-23 |
| 2019-09-30 | $-22 |
| 2019-06-30 | $-18 |
| 2019-03-31 | $-14 |
| 2018-12-31 | $-9 |
| 2018-09-30 | $-6 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-5 |
